vs

Side-by-side financial comparison of California Resources Corp (CRC) and NEOGENOMICS INC (NEO). Click either name above to swap in a different company.

NEOGENOMICS INC is the larger business by last-quarter revenue ($186.7M vs $119.0M, roughly 1.6× California Resources Corp). Over the past eight quarters, NEOGENOMICS INC's revenue compounded faster (6.5% CAGR vs -46.3%).

California Resources Corporation is an American energy corporation engaged in hydrocarbon exploration in California. It is organized in Delaware and headquartered in Long Beach, California. Its mineral acreage holdings in California constitute the largest privately held position in the state.

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

CRC vs NEO — Head-to-Head

Bigger by revenue
NEO
NEO
1.6× larger
NEO
$186.7M
$119.0M
CRC
Faster 2-yr revenue CAGR
NEO
NEO
Annualised
NEO
6.5%
-46.3%
CRC

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CRC
CRC
NEO
NEO
Revenue
$119.0M
$186.7M
Net Profit
$-108.0M
Gross Margin
43.3%
Operating Margin
-597.5%
46.9%
Net Margin
-57.9%
Revenue YoY
11.1%
Net Profit YoY
42.0%
EPS (diluted)
$-8.02
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRC
CRC
NEO
NEO
Q1 26
$119.0M
$186.7M
Q4 25
$679.0M
$190.2M
Q3 25
$715.0M
$187.8M
Q2 25
$702.0M
$181.3M
Q1 25
$814.0M
$168.0M
Q4 24
$826.0M
$172.0M
Q3 24
$870.0M
$167.8M
Q2 24
$412.0M
$164.5M
Net Profit
CRC
CRC
NEO
NEO
Q1 26
$-108.0M
Q4 25
$12.0M
Q3 25
$64.0M
$-27.1M
Q2 25
$172.0M
$-45.1M
Q1 25
$115.0M
$-25.9M
Q4 24
$33.0M
Q3 24
$345.0M
$-17.7M
Q2 24
$8.0M
$-18.6M
Gross Margin
CRC
CRC
NEO
NEO
Q1 26
43.3%
Q4 25
43.8%
Q3 25
42.8%
Q2 25
42.6%
Q1 25
43.6%
Q4 24
44.9%
Q3 24
44.6%
Q2 24
44.1%
Operating Margin
CRC
CRC
NEO
NEO
Q1 26
-597.5%
46.9%
Q4 25
6.9%
-7.1%
Q3 25
13.7%
-14.4%
Q2 25
38.0%
-26.3%
Q1 25
22.9%
-16.6%
Q4 24
8.2%
-10.7%
Q3 24
59.5%
-12.6%
Q2 24
9.2%
-13.3%
Net Margin
CRC
CRC
NEO
NEO
Q1 26
-57.9%
Q4 25
1.8%
Q3 25
9.0%
-14.4%
Q2 25
24.5%
-24.9%
Q1 25
14.1%
-15.4%
Q4 24
4.0%
Q3 24
39.7%
-10.5%
Q2 24
1.9%
-11.3%
EPS (diluted)
CRC
CRC
NEO
NEO
Q1 26
$-8.02
$-0.13
Q4 25
$0.21
Q3 25
$0.76
Q2 25
$1.92
Q1 25
$1.26
Q4 24
$0.87
Q3 24
$3.78
Q2 24
$0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRC
CRC
NEO
NEO
Cash + ST InvestmentsLiquidity on hand
$146.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.9B
$828.8M
Total Assets
$1.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRC
CRC
NEO
NEO
Q1 26
$146.1M
Q4 25
$132.0M
$159.6M
Q3 25
$196.0M
$164.1M
Q2 25
$72.0M
$154.7M
Q1 25
$214.0M
$346.2M
Q4 24
$372.0M
$367.0M
Q3 24
$241.0M
$362.0M
Q2 24
$1.0B
$355.1M
Total Debt
CRC
CRC
NEO
NEO
Q1 26
Q4 25
$341.9M
Q3 25
$1.0B
Q2 25
$1.0B
Q1 25
$1.0B
Q4 24
$1.1B
$541.1M
Q3 24
$1.1B
Q2 24
$1.2B
Stockholders' Equity
CRC
CRC
NEO
NEO
Q1 26
$2.9B
$828.8M
Q4 25
$3.7B
$836.6M
Q3 25
$3.4B
$838.3M
Q2 25
$3.4B
$854.0M
Q1 25
$3.5B
$888.3M
Q4 24
$3.5B
$902.3M
Q3 24
$3.5B
$908.2M
Q2 24
$2.1B
$915.9M
Total Assets
CRC
CRC
NEO
NEO
Q1 26
$1.3B
Q4 25
$7.4B
$1.4B
Q3 25
$6.8B
$1.4B
Q2 25
$6.7B
$1.4B
Q1 25
$6.8B
$1.6B
Q4 24
$7.1B
$1.6B
Q3 24
$7.1B
$1.6B
Q2 24
$4.5B
$1.6B
Debt / Equity
CRC
CRC
NEO
NEO
Q1 26
Q4 25
0.41×
Q3 25
0.29×
Q2 25
0.30×
Q1 25
0.29×
Q4 24
0.32×
0.60×
Q3 24
0.32×
Q2 24
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRC
CRC
NEO
NEO
Operating Cash FlowLast quarter
$99.0M
$-8.1M
Free Cash FlowOCF − Capex
$-32.0M
FCF MarginFCF / Revenue
-26.9%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$380.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRC
CRC
NEO
NEO
Q1 26
$99.0M
$-8.1M
Q4 25
$235.0M
$1.3M
Q3 25
$279.0M
$8.9M
Q2 25
$165.0M
$20.3M
Q1 25
$186.0M
$-25.3M
Q4 24
$206.0M
$9.8M
Q3 24
$220.0M
$9.2M
Q2 24
$97.0M
$13.9M
Free Cash Flow
CRC
CRC
NEO
NEO
Q1 26
$-32.0M
Q4 25
$115.0M
$-6.5M
Q3 25
$188.0M
$570.0K
Q2 25
$109.0M
$14.0M
Q1 25
$131.0M
$-29.8M
Q4 24
$118.0M
$-1.8M
Q3 24
$141.0M
$-1.6M
Q2 24
$63.0M
$814.0K
FCF Margin
CRC
CRC
NEO
NEO
Q1 26
-26.9%
Q4 25
16.9%
-3.4%
Q3 25
26.3%
0.3%
Q2 25
15.5%
7.7%
Q1 25
16.1%
-17.8%
Q4 24
14.3%
-1.0%
Q3 24
16.2%
-0.9%
Q2 24
15.3%
0.5%
Capex Intensity
CRC
CRC
NEO
NEO
Q1 26
Q4 25
17.7%
4.1%
Q3 25
12.7%
4.4%
Q2 25
8.0%
3.5%
Q1 25
6.8%
2.7%
Q4 24
10.7%
6.7%
Q3 24
9.1%
6.4%
Q2 24
8.3%
8.0%
Cash Conversion
CRC
CRC
NEO
NEO
Q1 26
Q4 25
19.58×
Q3 25
4.36×
Q2 25
0.96×
Q1 25
1.62×
Q4 24
6.24×
Q3 24
0.64×
Q2 24
12.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons